期刊文献+

郎格罕组织细胞增生症25例 被引量:5

Clinical Analysis of 25 Cases of Langerhans Cell Histiocytosis
下载PDF
导出
摘要 目的探讨郎格罕组织细胞增生症(LCH)的临床特征,以提高诊断水平,减少误诊率。方法回顾性分析1996年1月-2006年2月病理诊断的25例LCH,对其临床症状、体征、实验室检查、影像学、病理检查、诊断及治疗进行分析。结果实验室检查血象、骨髓像、肺部X线缺乏特异性表现;骨骼X线病变以溶骨性骨质破坏多见;头颅CT/MRI为诊断颅底骨质破坏和蝶鞍病变的重要方法。本组EB病毒(EBV)-IgM抗体阳性3例(3/7例);体液免疫异常5例(5/10例),细胞免疫异常3例(3/10例)。本组误诊率52%,最长误诊时间7年。化疗近期疗效明显。结论LCH临床表现多样,误诊率高。LCH病因不明,少数病例有EB病毒感染证据和免疫功能异常。病理检查为主要诊断手段,应进一步行超微结构及免疫表型检查。 Objective To explore the clinical and laboratory characteristics of langerhans cell histiocytosis (LCH) in children, so as to improve diagnosis level and decrease misdiagnosis rate.Methods Twenty-five cases of LCH from Jan.1996 to Feb.2006 were analyzed by retrospective study. The clinical data were collected and abstracted for information regarding clinical symptom, physical sign, laboratory examination, imaging,pathology,diagnosis and treatment.Results Some laboratory findings in hemogram, bone marrow examination and chest X-ray were non-specific.The X-ray characteristic of skeleton was osteolysis. Computerized tomography and magnetic resonance imaging were important in defining the extent of lesion in fundus cranii and sella.Seven cases were examined for anti-Epstein-Barr virus(EBV) IgM, 3 cases were positive,5 and 3 cases out of 10 cases showed humoral and cellular immunity abnormality,respectively. The misdiagnosis rate was 52%,1 case had been misdiagnosed for 7 years. Chemotherapy was effective in the future.Conclusions The clinical manifestations of LCH varies widely, leading to high rate of misdiagnosis.The etiology of LCH is unclear,and some of our patients show the evidence of EBV infection or immunity abnormality. Definitive diagnosis of LCH is based on pathology. Ultrastructure and immunophenotype should be done to improve diagnosis level.
出处 《实用儿科临床杂志》 CAS CSCD 北大核心 2007年第3期204-205,217,共3页 Journal of Applied Clinical Pediatrics
关键词 郎格罕组织细胞增生症 临床分析 EB病毒 langerhans cell histiocytosis,clinical analysis,Epstein-Barr virus
  • 相关文献

参考文献9

二级参考文献46

  • 1赵新民,胡亚美.郎格罕细胞组织细胞增生症临床和实验研究[J].中华儿科杂志,1993,31(5):266-268. 被引量:18
  • 2杨士元.组织细胞增生症470例分析[J].中华儿科杂志,1983,21:265-265.
  • 3邓家栋 杨崇礼 杨天楹 等.临床血液病[M].上海:科学技术出版社,1985.820-828.
  • 4张之南 刘尔坤 李筱梅 等.血液诊断及疗效标准[M].天津:科学技术出版社,1990.327.
  • 5Favara BE, Feller AC, Pauli M, et al. Contemporary classification of histiocytic disorders. Med Pediatr Oncol, 1997, 29(3): 157-166.
  • 6Komp DM, Herson J, Starling KA, et al. A staging system for Histiocytosis X: a Southwest Oncology Group Study. Cancer, 1981, 47(4): 798-800.
  • 7Gadner H, Heitger A, Groris N, et al. Treatment stra-tegy for disseminated Langerhans cell histiocytosis. DAL HX-83 Study Group. Med Pediatr Oncol, 1994, 23(2): 72-80.
  • 8Titgemeyer C, Grois N, Minkov M, et al. Pattern and course of single-system disease in Langerhans cell histiocytosis data from the DAL-HX 83- and 90-study. Med Pediatr Oncol, 2001, 37(2): 108-114.
  • 9Ladisch S, Gadner H, Arico M, et al. LCH-I: a rando-mized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis.Med Pediatr Oncol, 1994, 23(2): 107-110
  • 10Carstensen H, Ornvold K. The epidemiology of Langer-hans cell histiocytosis in children in Denmark, 1975-1989. Med Pediatr Oncol, 1993, 21: 387-388.

共引文献32

同被引文献32

引证文献5

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部